Home › Funds › Spruce Street Capital LP › SRZN
Spruce Street Capital LP position in SRZN
SURROZEN INC · Health Care
Spruce Street Capital LP reported holding 432,040 shares of SRZN (SURROZEN INC) in its Q3 2026 13F filing — a position valued at US$13.9M, representing 2.21% of its reported portfolio and ranking #15 among its reported holdings. Spruce Street Capital LP has disclosed SRZN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's SRZN position evolved
Spruce Street Capital LP first disclosed a stake in SRZN in Q4 2025 at 432,040 shares (US$9.8M). The position peaked in Q3 2026 at 432,040 shares, worth US$13.9M. Across 4 filings, Spruce Street Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 432,040 shares valued at US$13.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 432.04K | $9.76M | New |
| Q1 2026 | 432.04K | $12.59M | Hold |
| Q2 2026 | 432.04K | $11.21M | Hold |
| Q3 2026 | 432.04K | $13.90M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRZN and 13F data
SRZN (SURROZEN INC) is a Health Care company. 52 other funds we track also report a position in SRZN — the largest reported positions include Column Group LLC (US$49.7M), TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRZN
- Column Group LLC 1.92M sh · $49.74M · Q2 2026
- TCG Crossover Management, LLC 1.47M sh · $38.23M · Q2 2026
- Boxer Capital Management, LLC 1.11M sh · $26.96M · Q2 2026
- Venrock Adviser, LLC 632.93K sh · $16.42M · Q2 2026
- STEMPOINT CAPITAL LP 602.80K sh · $13.79M · Q2 2026
- Kalehua Capital Management LLC 286.09K sh · $9.21M · Q3 2026
- Vivo Capital, LLC 260.00K sh · $8.37M · Q3 2026
- 5AM Venture Management, LLC 271.25K sh · $7.04M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 173.40K sh · $4.50M · Q2 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K sh · $4.29M · Q3 2026
- Euclidean Capital LLC 87.70K sh · $2.28M · Q2 2026
- Stonepine Capital Management, LLC 44.10K sh · $1.42M · Q3 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held SRZN?
Spruce Street Capital LP has disclosed SRZN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in SRZN?
As of Q3 2026, Spruce Street Capital LP holds 432.04K shares of SRZN (SURROZEN INC), valued at $13.90M, representing 2.21% of its reported portfolio and ranking #15.
Has Spruce Street Capital LP been buying or selling SRZN?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in SRZN. The position peaked in Q3 2026 at 432.04K shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include Column Group LLC, TCG Crossover Management, LLC, Boxer Capital Management, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.